Reports

Industry Research Reports

Home > Reports > Chemical & Material > Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-03-10

Pages: 112 Pages

Report ld: 4522400

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Bifidobacterium Longum Subsp. Infantis M-63 Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

6.2%

marketSize

Market Size,2031

USD 67.7

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 47.2 million
Market Forecast in 2031(Value)
US$ 67.7 million
CAGR
6.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Bifidobacterium Longum Subsp. Infantis M-63 market size was US$ 44.7 million in 2024 and is forecast to a readjusted size of US$ 67.7 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

Bifidobacterium Longum Subsp. Infantis M-63 is a subspecies of Bifidobacterium longum infantis that mainly inhabits the intestines of human infants. Clinical studies have shown that it has a strong ability to utilize human milk oligosaccharides (HMO) contained in breast milk, which can improve the intestinal environment of healthy infants and young children. It is also known as the probiotic of the new era of HMO.

The North America Bifidobacterium Longum Subsp. Infantis M-63 market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key manufacturers of Bifidobacterium Longum Subsp. Infantis M-63 include Mitushi Biopharma, Fengchen Group, Jiangsu Wecare Biotechnology Co., Ltd., Shenzhen Lefu Biotechnology Co., Ltd., Hebei Hongtao Bioengineering Co., Ltd., Shandong Junle Biotechnology Co., Ltd., Shandong Xinxiong Biotechnology Co., Ltd., Newgen Biotech, Pharm-Rx, Rajvi Enterprise, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Bifidobacterium Longum Subsp. Infantis M-63 market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

  • Mitushi Biopharma
  • Fengchen Group
  • Jiangsu Wecare Biotechnology Co., Ltd.
  • Shenzhen Lefu Biotechnology Co., Ltd.
  • Hebei Hongtao Bioengineering Co., Ltd.
  • Shandong Junle Biotechnology Co., Ltd.
  • Shandong Xinxiong Biotechnology Co., Ltd.
  • Newgen Biotech
  • Pharm-Rx
  • Rajvi Enterprise
  • Shandong Pingao Pharmaceutical Co., Ltd.
  • Shaanxi Chenming Biotechnology Co., Ltd.
  • Xi'an Minglang Biotechnology Co., Ltd.
  • Jiahe Biotechnology (Shanxi) Co., Ltd.
  • Shaanxi Ruimao Biotechnology Co., Ltd.
  • Shaanxi Baohe Biotechnology Co., Ltd.
  • Shaanxi Lesent Biotechnology Co., Ltd.
  • Shaanxi Shuoyang Biotechnology Co., Ltd.
  • Shaanxi Mufan Biotechnology Co., Ltd.
  • Xi'an An'Drong Biomedical Technology Co., Ltd.
  • Shaanxi Guanchen Biotechnology Co., Ltd.

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • 0-50 billion CFU/g
  • 50-100 billion CFU/g
  • ＞100 billion CFU/g

Segment by Application

  • Food Additives
  • Medicines and Supplements
  • Feed Additives
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

marn_i1

Chapter 2: Quantitative analysis of Bifidobacterium Longum Subsp. Infantis M-63 market size and growth potential at global, regional, and country levels.

marn_i1

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

marn_i1

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 50-100 billion CFU/g in China).

marn_i1

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Medicines and Supplements in India).

marn_i1

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

marn_i1

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

marn_i1

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Bifidobacterium Longum Subsp. Infantis M-63 value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Market Overview

1.1 Bifidobacterium Longum Subsp. Infantis M-63 Product Scope

1.2 Bifidobacterium Longum Subsp. Infantis M-63 by Type

1.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales by Type (2020 & 2024 & 2031)

1.2.2 0-50 billion CFU/g

1.2.3 50-100 billion CFU/g

1.2.4 ＞100 billion CFU/g

1.3 Bifidobacterium Longum Subsp. Infantis M-63 by Application

1.3.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Food Additives

1.3.3 Medicines and Supplements

1.3.4 Feed Additives

1.3.5 Others

1.4 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Estimates and Forecasts (2020-2031)

1.4.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Price Trends (2020-2031)

1.5 Assumptions and Limitations

muLu

2 Market Size and Prospective by Region

2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Region (2020-2025)

2.2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Market Share by Region (2020-2025)

2.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Bifidobacterium Longum Subsp. Infantis M-63 Market Size and Prospective (2020-2031)

2.4.2 Europe Bifidobacterium Longum Subsp. Infantis M-63 Market Size and Prospective (2020-2031)

2.4.3 China Bifidobacterium Longum Subsp. Infantis M-63 Market Size and Prospective (2020-2031)

2.4.4 Japan Bifidobacterium Longum Subsp. Infantis M-63 Market Size and Prospective (2020-2031)

muLu

3 Global Market Size by Type

3.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Historic Market Review by Type (2020-2025)

3.1.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales by Type (2020-2025)

3.1.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Type (2020-2025)

3.1.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Type (2020-2025)

3.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Forecast by Type (2026-2031)

3.2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Forecast by Type (2026-2031)

3.2.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Price Forecast by Type (2026-2031)

3.3 Different Types Bifidobacterium Longum Subsp. Infantis M-63 Representative Players

muLu

4 Global Market Size by Application

4.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Historic Market Review by Application (2020-2025)

4.1.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales by Application (2020-2025)

4.1.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Application (2020-2025)

4.1.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Application (2020-2025)

4.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Forecast by Application (2026-2031)

4.2.2 Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Forecast by Application (2026-2031)

4.2.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Bifidobacterium Longum Subsp. Infantis M-63 Application

muLu

5 Competition Landscape by Players

5.1 Global Bifidobacterium Longum Subsp. Infantis M-63 Sales by Players (2020-2025)

5.2 Global Top Bifidobacterium Longum Subsp. Infantis M-63 Players by Revenue (2020-2025)

5.3 Global Bifidobacterium Longum Subsp. Infantis M-63 Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bifidobacterium Longum Subsp. Infantis M-63 as of 2024)

5.4 Global Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Bifidobacterium Longum Subsp. Infantis M-63, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Bifidobacterium Longum Subsp. Infantis M-63, Product Type & Application

5.7 Global Key Manufacturers of Bifidobacterium Longum Subsp. Infantis M-63, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

muLu

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company

6.1.1.1 North America Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company (2020-2025)

6.1.1.2 North America Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Company (2020-2025)

6.1.2 North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Breakdown by Type (2020-2025)

6.1.3 North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Breakdown by Application (2020-2025)

6.1.4 North America Bifidobacterium Longum Subsp. Infantis M-63 Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company

6.2.1.1 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company (2020-2025)

6.2.1.2 Europe Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Company (2020-2025)

6.2.2 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Breakdown by Type (2020-2025)

6.2.3 Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Breakdown by Application (2020-2025)

6.2.4 Europe Bifidobacterium Longum Subsp. Infantis M-63 Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company

6.3.1.1 China Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company (2020-2025)

6.3.1.2 China Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Company (2020-2025)

6.3.2 China Bifidobacterium Longum Subsp. Infantis M-63 Sales Breakdown by Type (2020-2025)

6.3.3 China Bifidobacterium Longum Subsp. Infantis M-63 Sales Breakdown by Application (2020-2025)

6.3.4 China Bifidobacterium Longum Subsp. Infantis M-63 Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company

6.4.1.1 Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company (2020-2025)

6.4.1.2 Japan Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Company (2020-2025)

6.4.2 Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales Breakdown by Type (2020-2025)

6.4.3 Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales Breakdown by Application (2020-2025)

6.4.4 Japan Bifidobacterium Longum Subsp. Infantis M-63 Major Customer

6.4.5 Japan Market Trend and Opportunities

muLu

7 Company Profiles and Key Figures

7.1 Mitushi Biopharma

7.1.1 Mitushi Biopharma Company Information

7.1.2 Mitushi Biopharma Business Overview

7.1.3 Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.1.5 Mitushi Biopharma Recent Development

7.2 Fengchen Group

7.2.1 Fengchen Group Company Information

7.2.2 Fengchen Group Business Overview

7.2.3 Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.2.5 Fengchen Group Recent Development

7.3 Jiangsu Wecare Biotechnology Co., Ltd.

7.3.1 Jiangsu Wecare Biotechnology Co., Ltd. Company Information

7.3.2 Jiangsu Wecare Biotechnology Co., Ltd. Business Overview

7.3.3 Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.3.5 Jiangsu Wecare Biotechnology Co., Ltd. Recent Development

7.4 Shenzhen Lefu Biotechnology Co., Ltd.

7.4.1 Shenzhen Lefu Biotechnology Co., Ltd. Company Information

7.4.2 Shenzhen Lefu Biotechnology Co., Ltd. Business Overview

7.4.3 Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.4.5 Shenzhen Lefu Biotechnology Co., Ltd. Recent Development

7.5 Hebei Hongtao Bioengineering Co., Ltd.

7.5.1 Hebei Hongtao Bioengineering Co., Ltd. Company Information

7.5.2 Hebei Hongtao Bioengineering Co., Ltd. Business Overview

7.5.3 Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.5.4 Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.5.5 Hebei Hongtao Bioengineering Co., Ltd. Recent Development

7.6 Shandong Junle Biotechnology Co., Ltd.

7.6.1 Shandong Junle Biotechnology Co., Ltd. Company Information

7.6.2 Shandong Junle Biotechnology Co., Ltd. Business Overview

7.6.3 Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.6.5 Shandong Junle Biotechnology Co., Ltd. Recent Development

7.7 Shandong Xinxiong Biotechnology Co., Ltd.

7.7.1 Shandong Xinxiong Biotechnology Co., Ltd. Company Information

7.7.2 Shandong Xinxiong Biotechnology Co., Ltd. Business Overview

7.7.3 Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.7.5 Shandong Xinxiong Biotechnology Co., Ltd. Recent Development

7.8 Newgen Biotech

7.8.1 Newgen Biotech Company Information

7.8.2 Newgen Biotech Business Overview

7.8.3 Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.8.5 Newgen Biotech Recent Development

7.9 Pharm-Rx

7.9.1 Pharm-Rx Company Information

7.9.2 Pharm-Rx Business Overview

7.9.3 Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.9.5 Pharm-Rx Recent Development

7.10 Rajvi Enterprise

7.10.1 Rajvi Enterprise Company Information

7.10.2 Rajvi Enterprise Business Overview

7.10.3 Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.10.5 Rajvi Enterprise Recent Development

7.11 Shandong Pingao Pharmaceutical Co., Ltd.

7.11.1 Shandong Pingao Pharmaceutical Co., Ltd. Company Information

7.11.2 Shandong Pingao Pharmaceutical Co., Ltd. Business Overview

7.11.3 Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.11.5 Shandong Pingao Pharmaceutical Co., Ltd. Recent Development

7.12 Shaanxi Chenming Biotechnology Co., Ltd.

7.12.1 Shaanxi Chenming Biotechnology Co., Ltd. Company Information

7.12.2 Shaanxi Chenming Biotechnology Co., Ltd. Business Overview

7.12.3 Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.12.5 Shaanxi Chenming Biotechnology Co., Ltd. Recent Development

7.13 Xi'an Minglang Biotechnology Co., Ltd.

7.13.1 Xi'an Minglang Biotechnology Co., Ltd. Company Information

7.13.2 Xi'an Minglang Biotechnology Co., Ltd. Business Overview

7.13.3 Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.13.4 Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.13.5 Xi'an Minglang Biotechnology Co., Ltd. Recent Development

7.14 Jiahe Biotechnology (Shanxi) Co., Ltd.

7.14.1 Jiahe Biotechnology (Shanxi) Co., Ltd. Company Information

7.14.2 Jiahe Biotechnology (Shanxi) Co., Ltd. Business Overview

7.14.3 Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.14.4 Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.14.5 Jiahe Biotechnology (Shanxi) Co., Ltd. Recent Development

7.15 Shaanxi Ruimao Biotechnology Co., Ltd.

7.15.1 Shaanxi Ruimao Biotechnology Co., Ltd. Company Information

7.15.2 Shaanxi Ruimao Biotechnology Co., Ltd. Business Overview

7.15.3 Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.15.4 Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.15.5 Shaanxi Ruimao Biotechnology Co., Ltd. Recent Development

7.16 Shaanxi Baohe Biotechnology Co., Ltd.

7.16.1 Shaanxi Baohe Biotechnology Co., Ltd. Company Information

7.16.2 Shaanxi Baohe Biotechnology Co., Ltd. Business Overview

7.16.3 Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.16.4 Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.16.5 Shaanxi Baohe Biotechnology Co., Ltd. Recent Development

7.17 Shaanxi Lesent Biotechnology Co., Ltd.

7.17.1 Shaanxi Lesent Biotechnology Co., Ltd. Company Information

7.17.2 Shaanxi Lesent Biotechnology Co., Ltd. Business Overview

7.17.3 Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.17.4 Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.17.5 Shaanxi Lesent Biotechnology Co., Ltd. Recent Development

7.18 Shaanxi Shuoyang Biotechnology Co., Ltd.

7.18.1 Shaanxi Shuoyang Biotechnology Co., Ltd. Company Information

7.18.2 Shaanxi Shuoyang Biotechnology Co., Ltd. Business Overview

7.18.3 Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.18.4 Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.18.5 Shaanxi Shuoyang Biotechnology Co., Ltd. Recent Development

7.19 Shaanxi Mufan Biotechnology Co., Ltd.

7.19.1 Shaanxi Mufan Biotechnology Co., Ltd. Company Information

7.19.2 Shaanxi Mufan Biotechnology Co., Ltd. Business Overview

7.19.3 Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.19.4 Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.19.5 Shaanxi Mufan Biotechnology Co., Ltd. Recent Development

7.20 Xi'an An'Drong Biomedical Technology Co., Ltd.

7.20.1 Xi'an An'Drong Biomedical Technology Co., Ltd. Company Information

7.20.2 Xi'an An'Drong Biomedical Technology Co., Ltd. Business Overview

7.20.3 Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.20.4 Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.20.5 Xi'an An'Drong Biomedical Technology Co., Ltd. Recent Development

7.21 Shaanxi Guanchen Biotechnology Co., Ltd.

7.21.1 Shaanxi Guanchen Biotechnology Co., Ltd. Company Information

7.21.2 Shaanxi Guanchen Biotechnology Co., Ltd. Business Overview

7.21.3 Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales, Revenue and Gross Margin (2020-2025)

7.21.4 Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Products Offered

7.21.5 Shaanxi Guanchen Biotechnology Co., Ltd. Recent Development

muLu

8 Bifidobacterium Longum Subsp. Infantis M-63 Manufacturing Cost Analysis

8.1 Bifidobacterium Longum Subsp. Infantis M-63 Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Bifidobacterium Longum Subsp. Infantis M-63

8.4 Bifidobacterium Longum Subsp. Infantis M-63 Industrial Chain Analysis

muLu

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Bifidobacterium Longum Subsp. Infantis M-63 Distributors List

9.3 Bifidobacterium Longum Subsp. Infantis M-63 Customers

muLu

10 Bifidobacterium Longum Subsp. Infantis M-63 Market Dynamics

10.1 Bifidobacterium Longum Subsp. Infantis M-63 Industry Trends

10.2 Bifidobacterium Longum Subsp. Infantis M-63 Market Drivers

10.3 Bifidobacterium Longum Subsp. Infantis M-63 Market Challenges

10.4 Bifidobacterium Longum Subsp. Infantis M-63 Market Restraints

muLu

11 Research Findings and Conclusion

muLu

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Bifidobacterium Longum Subsp. Infantis M-63 Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons) by Region (2020-2025)
Table 5. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Region (2020-2025)
Table 6. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Share by Region (2020-2025)
Table 8. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons) Forecast by Region (2026-2031)
Table 9. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Share Forecast by Region (2026-2031)
Table 12. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales by Type (Tons) & (2020-2025)
Table 13. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Share by Type (2020-2025)
Table 14. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Type (US$/Ton) & (2020-2025)
Table 16. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales by Type (Tons) & (2026-2031)
Table 17. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Type (US$/Ton) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales by Application (Tons) & (2020-2025)
Table 21. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Share by Application (2020-2025)
Table 22. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Application (US$/Ton) & (2020-2025)
Table 24. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales by Application (Tons) & (2026-2031)
Table 25. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Bifidobacterium Longum Subsp. Infantis M-63 Price by Application (US$/Ton) & (2026-2031)
Table 27. New Sources of Growth in Bifidobacterium Longum Subsp. Infantis M-63 Application
Table 28. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company (Tons) & (2020-2025)
Table 29. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Share by Company (2020-2025)
Table 30. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Share by Company (2020-2025)
Table 32. Global Bifidobacterium Longum Subsp. Infantis M-63 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bifidobacterium Longum Subsp. Infantis M-63 as of 2024)
Table 33. Global Market Bifidobacterium Longum Subsp. Infantis M-63 Average Price by Company (US$/Ton) & (2020-2025)
Table 34. Global Key Manufacturers of Bifidobacterium Longum Subsp. Infantis M-63, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Bifidobacterium Longum Subsp. Infantis M-63, Product Type & Application
Table 36. Global Key Manufacturers of Bifidobacterium Longum Subsp. Infantis M-63, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company (2020-2025) & (Tons)
Table 39. North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Company (2020-2025)
Table 40. North America Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Bifidobacterium Longum Subsp. Infantis M-63 Revenue Market Share by Company (2020-2025)
Table 42. North America Bifidobacterium Longum Subsp. Infantis M-63 Sales by Type (2020-2025) & (Tons)
Table 43. North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Type (2020-2025)
Table 44. North America Bifidobacterium Longum Subsp. Infantis M-63 Sales by Application (2020-2025) & (Tons)
Table 45. North America Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Application (2020-2025)
Table 46. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company (2020-2025) & (Tons)
Table 47. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Company (2020-2025)
Table 48. Europe Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Bifidobacterium Longum Subsp. Infantis M-63 Revenue Market Share by Company (2020-2025)
Table 50. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales by Type (2020-2025) & (Tons)
Table 51. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Type (2020-2025)
Table 52. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales by Application (2020-2025) & (Tons)
Table 53. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Application (2020-2025)
Table 54. China Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company (2020-2025) & (Tons)
Table 55. China Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Company (2020-2025)
Table 56. China Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Bifidobacterium Longum Subsp. Infantis M-63 Revenue Market Share by Company (2020-2025)
Table 58. China Bifidobacterium Longum Subsp. Infantis M-63 Sales by Type (2020-2025) & (Tons)
Table 59. China Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Type (2020-2025)
Table 60. China Bifidobacterium Longum Subsp. Infantis M-63 Sales by Application (2020-2025) & (Tons)
Table 61. China Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Application (2020-2025)
Table 62. Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales by Company (2020-2025) & (Tons)
Table 63. Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Company (2020-2025)
Table 64. Japan Bifidobacterium Longum Subsp. Infantis M-63 Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Bifidobacterium Longum Subsp. Infantis M-63 Revenue Market Share by Company (2020-2025)
Table 66. Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales by Type (2020-2025) & (Tons)
Table 67. Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Type (2020-2025)
Table 68. Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales by Application (2020-2025) & (Tons)
Table 69. Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Application (2020-2025)
Table 70. Mitushi Biopharma Company Information
Table 71. Mitushi Biopharma Description and Business Overview
Table 72. Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Mitushi Biopharma Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 74. Mitushi Biopharma Recent Development
Table 75. Fengchen Group Company Information
Table 76. Fengchen Group Description and Business Overview
Table 77. Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Fengchen Group Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 79. Fengchen Group Recent Development
Table 80. Jiangsu Wecare Biotechnology Co., Ltd. Company Information
Table 81. Jiangsu Wecare Biotechnology Co., Ltd. Description and Business Overview
Table 82. Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Jiangsu Wecare Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 84. Jiangsu Wecare Biotechnology Co., Ltd. Recent Development
Table 85. Shenzhen Lefu Biotechnology Co., Ltd. Company Information
Table 86. Shenzhen Lefu Biotechnology Co., Ltd. Description and Business Overview
Table 87. Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Shenzhen Lefu Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 89. Shenzhen Lefu Biotechnology Co., Ltd. Recent Development
Table 90. Hebei Hongtao Bioengineering Co., Ltd. Company Information
Table 91. Hebei Hongtao Bioengineering Co., Ltd. Description and Business Overview
Table 92. Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Hebei Hongtao Bioengineering Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 94. Hebei Hongtao Bioengineering Co., Ltd. Recent Development
Table 95. Shandong Junle Biotechnology Co., Ltd. Company Information
Table 96. Shandong Junle Biotechnology Co., Ltd. Description and Business Overview
Table 97. Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Shandong Junle Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 99. Shandong Junle Biotechnology Co., Ltd. Recent Development
Table 100. Shandong Xinxiong Biotechnology Co., Ltd. Company Information
Table 101. Shandong Xinxiong Biotechnology Co., Ltd. Description and Business Overview
Table 102. Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Shandong Xinxiong Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 104. Shandong Xinxiong Biotechnology Co., Ltd. Recent Development
Table 105. Newgen Biotech Company Information
Table 106. Newgen Biotech Description and Business Overview
Table 107. Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Newgen Biotech Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 109. Newgen Biotech Recent Development
Table 110. Pharm-Rx Company Information
Table 111. Pharm-Rx Description and Business Overview
Table 112. Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Pharm-Rx Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 114. Pharm-Rx Recent Development
Table 115. Rajvi Enterprise Company Information
Table 116. Rajvi Enterprise Description and Business Overview
Table 117. Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. Rajvi Enterprise Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 119. Rajvi Enterprise Recent Development
Table 120. Shandong Pingao Pharmaceutical Co., Ltd. Company Information
Table 121. Shandong Pingao Pharmaceutical Co., Ltd. Description and Business Overview
Table 122. Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. Shandong Pingao Pharmaceutical Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 124. Shandong Pingao Pharmaceutical Co., Ltd. Recent Development
Table 125. Shaanxi Chenming Biotechnology Co., Ltd. Company Information
Table 126. Shaanxi Chenming Biotechnology Co., Ltd. Description and Business Overview
Table 127. Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. Shaanxi Chenming Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 129. Shaanxi Chenming Biotechnology Co., Ltd. Recent Development
Table 130. Xi'an Minglang Biotechnology Co., Ltd. Company Information
Table 131. Xi'an Minglang Biotechnology Co., Ltd. Description and Business Overview
Table 132. Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 133. Xi'an Minglang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 134. Xi'an Minglang Biotechnology Co., Ltd. Recent Development
Table 135. Jiahe Biotechnology (Shanxi) Co., Ltd. Company Information
Table 136. Jiahe Biotechnology (Shanxi) Co., Ltd. Description and Business Overview
Table 137. Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 138. Jiahe Biotechnology (Shanxi) Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 139. Jiahe Biotechnology (Shanxi) Co., Ltd. Recent Development
Table 140. Shaanxi Ruimao Biotechnology Co., Ltd. Company Information
Table 141. Shaanxi Ruimao Biotechnology Co., Ltd. Description and Business Overview
Table 142. Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 143. Shaanxi Ruimao Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 144. Shaanxi Ruimao Biotechnology Co., Ltd. Recent Development
Table 145. Shaanxi Baohe Biotechnology Co., Ltd. Company Information
Table 146. Shaanxi Baohe Biotechnology Co., Ltd. Description and Business Overview
Table 147. Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 148. Shaanxi Baohe Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 149. Shaanxi Baohe Biotechnology Co., Ltd. Recent Development
Table 150. Shaanxi Lesent Biotechnology Co., Ltd. Company Information
Table 151. Shaanxi Lesent Biotechnology Co., Ltd. Description and Business Overview
Table 152. Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 153. Shaanxi Lesent Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 154. Shaanxi Lesent Biotechnology Co., Ltd. Recent Development
Table 155. Shaanxi Shuoyang Biotechnology Co., Ltd. Company Information
Table 156. Shaanxi Shuoyang Biotechnology Co., Ltd. Description and Business Overview
Table 157. Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 158. Shaanxi Shuoyang Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 159. Shaanxi Shuoyang Biotechnology Co., Ltd. Recent Development
Table 160. Shaanxi Mufan Biotechnology Co., Ltd. Company Information
Table 161. Shaanxi Mufan Biotechnology Co., Ltd. Description and Business Overview
Table 162. Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 163. Shaanxi Mufan Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 164. Shaanxi Mufan Biotechnology Co., Ltd. Recent Development
Table 165. Xi'an An'Drong Biomedical Technology Co., Ltd. Company Information
Table 166. Xi'an An'Drong Biomedical Technology Co., Ltd. Description and Business Overview
Table 167. Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 168. Xi'an An'Drong Biomedical Technology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 169. Xi'an An'Drong Biomedical Technology Co., Ltd. Recent Development
Table 170. Shaanxi Guanchen Biotechnology Co., Ltd. Company Information
Table 171. Shaanxi Guanchen Biotechnology Co., Ltd. Description and Business Overview
Table 172. Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 173. Shaanxi Guanchen Biotechnology Co., Ltd. Bifidobacterium Longum Subsp. Infantis M-63 Product
Table 174. Shaanxi Guanchen Biotechnology Co., Ltd. Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Bifidobacterium Longum Subsp. Infantis M-63 Distributors List
Table 178. Bifidobacterium Longum Subsp. Infantis M-63 Customers List
Table 179. Bifidobacterium Longum Subsp. Infantis M-63 Market Trends
Table 180. Bifidobacterium Longum Subsp. Infantis M-63 Market Drivers
Table 181. Bifidobacterium Longum Subsp. Infantis M-63 Market Challenges
Table 182. Bifidobacterium Longum Subsp. Infantis M-63 Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. Bifidobacterium Longum Subsp. Infantis M-63 Product Picture
Figure 2. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Type in 2024 & 2031
Figure 4. 0-50 billion CFU/g Product Picture
Figure 5. 50-100 billion CFU/g Product Picture
Figure 6. ＞100 billion CFU/g Product Picture
Figure 7. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Share by Application in 2024 & 2031
Figure 9. Food Additives Examples
Figure 10. Medicines and Supplements Examples
Figure 11. Feed Additives Examples
Figure 12. Others Examples
Figure 13. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Growth Rate (2020-2031) & (US$ Million)
Figure 15. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons) Growth Rate (2020-2031)
Figure 16. Global Bifidobacterium Longum Subsp. Infantis M-63 Price Trends Growth Rate (2020-2031) & (US$/Ton)
Figure 17. Bifidobacterium Longum Subsp. Infantis M-63 Report Years Considered
Figure 18. Global Market Bifidobacterium Longum Subsp. Infantis M-63 Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 19. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Market Share by Region: 2020 VS 2024
Figure 20. North America Bifidobacterium Longum Subsp. Infantis M-63 Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. North America Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons) Growth Rate (2020-2031)
Figure 22. Europe Bifidobacterium Longum Subsp. Infantis M-63 Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Europe Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons) Growth Rate (2020-2031)
Figure 24. China Bifidobacterium Longum Subsp. Infantis M-63 Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. China Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons) Growth Rate (2020-2031)
Figure 26. Japan Bifidobacterium Longum Subsp. Infantis M-63 Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Bifidobacterium Longum Subsp. Infantis M-63 Sales (Tons) Growth Rate (2020-2031)
Figure 28. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Share by Type (2020-2025)
Figure 29. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Share by Type (2026-2031)
Figure 30. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Share by Type (2026-2031)
Figure 31. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Share by Application (2020-2025)
Figure 32. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Share by Application (2026-2031)
Figure 34. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Share by Application (2026-2031)
Figure 35. Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Share by Company (2024)
Figure 36. Global Bifidobacterium Longum Subsp. Infantis M-63 Revenue Share by Company (2024)
Figure 37. Global 5 Largest Bifidobacterium Longum Subsp. Infantis M-63 Players Market Share by Revenue in Bifidobacterium Longum Subsp. Infantis M-63: 2020 & 2024
Figure 38. Bifidobacterium Longum Subsp. Infantis M-63 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Bifidobacterium Longum Subsp. Infantis M-63
Figure 40. Manufacturing Process Analysis of Bifidobacterium Longum Subsp. Infantis M-63
Figure 41. Bifidobacterium Longum Subsp. Infantis M-63 Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Bifidobacterium Longum Subsp. Infantis M-63 market?zhanKai
The top companies in the global Bifidobacterium Longum Subsp. Infantis M-63 market are Mitushi Biopharma、Fengchen Group、Jiangsu Wecare Biotechnology Co., Ltd..
What was the global market size of Bifidobacterium Longum Subsp. Infantis M-63 in 2031?shouQi
What is the annual compound growth rate of the global Bifidobacterium Longum Subsp. Infantis M-63 market size from 2025 to 2031?shouQi
Which region is expected to have the highest market share?shouQi
What was the global market size of Bifidobacterium Longum Subsp. Infantis M-63 in 2025?shouQi
den_biaoTiZhungShi

Related Reports

Global Bifidobacterium Longum Subsp. Infantis M-63 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-03-10

Pages: 112 Pages

Report ld: 4522400

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

SIMON LEE

+1-62 6295 2442

English,Chinese

Online

HITESH

HITESH

+91-86 6998 6909

English, Hindi

Offline

TANG XIN

TANG XIN

+81-90 3800 9273

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

YUJIE TIAN

+86-135-2215-3954

Chinese, English

Offline

DAMON

DAMON

+86-133 1872 9947

Chinese, English

Offline

General Email:
global@qyresearch.com

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now